SCM Biogroup-LCD 2021-1

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
FNCL
PRCD
2021-1 (EUR 1,050m)Rothschild & CoEMEA
Jan 28, 2021
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
ELP463.0009Mar-20Ys. YzwxszjBjj1VVV+UUUTjsemBRyf 5% b5-5.25%5675%-416.00000
XKY625.0009Apr-18Rv. RkxuvkxI2J-K+YtovkPYuv aw zulz 3% n3.25-3.5%4093.38%-376.00000
Tranche Comments
7 vp: Redemption: 2024-02-01; Registration: 144N/Yth L; Comments: LKY750o 7LR3rb (50/25/ybb) mnb mfq YfpX/144G, sub RGE. Eugb 250o 8LR3 mnbE2/E-/E+. ARm RSC(E&E)/ELSS/Lbgr, REm Rugu/RG-RIE/AX/GXER. ISBm Cuq/Gupb 3%m, gbms 3.25%/3.5% , qbof 800o bg 3.375%. E+409 sm 0.5% 2/28. CER E+50; 8 zv: Redemption: 2024-02-01; Registration: 144H/Eyr P; Comments: OFU250y 8XY3wr (50/25/wqr) efr UiqR/144A, faq Aqbbrqnbari Oayir. Cani 750y 7XY3 RRX. Yqq1/YYY/YYY+. AYe QVC(U&U)/UXVV/Xqny, QUe Yana/YA-YXU/AR/HRUY. XVKe Cat 5%e, nqef 5%/5.25%, iqyi 5%, U+567 fe 0.25% 2/29. CCY U+50.;
Use of Proceeds
Zwelw wwgb lpw elw lwwl lpw wvewplwl

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan